2021 Pharmaceutical Companies Vaccines 
pharmaphorum
JANUARY 5, 2021
In the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that will affect the global healthcare and pharmaceutical industries in 2021. One bright spot in an otherwise dreadful year: the pharmaceutical industry has discovered it can do things it never dreamed possible.
Pharma Marketing Network
JANUARY 6, 2021
Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021. Tools that help people track their health, including apps, wearables, and patient portals will be used more than ever in 2021. For example, people mistrust the efficiency and safety of the COVID-19 vaccine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 31, 2022
It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.
European Pharmaceutical Review
OCTOBER 24, 2022
The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ). million people living with rare diseases in the UK.
pharmaphorum
OCTOBER 18, 2021
The development of COVID-19 vaccines required levels of cooperation and pioneering science comparable to the Apollo space programme. Within 12 months of the outbreak, vaccines were being deployed to prevent severe infections, hospitalisation, and death. billion people have been fully vaccinated. Last accessed: October 2021.
PharmaShots
APRIL 25, 2023
Numerous pharmaceutical companies have developed and authorized vaccines to provide immunity against COVID-19. Despite the drenched market of covid products, many other drugs have set an impressive benchmark for pharmaceutical companies in 2021. Watch out for the full report on Dupixent tomorrow. Stay tuned!
pharmaphorum
MAY 5, 2021
Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world’s biggest-selling medicines. . The vaccine made $3.5 The vaccine made $3.5 The sales forecast for 2021 is based on contracts to deliver 1.6 billion. .
Expert insights. Personalized for you.
105 
Let's personalize your content